Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 435.00
+8.50 (1.99%)
Sep 4, 2026, 4:35 PM GMT
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 516.23 million as of September 4, 2026. Its market cap has decreased by -25.30% in one year.
Market Cap
516.23M
Enterprise Value
567.45M
Revenue
168.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
435.00
ChartMarket Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 516.23M, an increase of 2,867.90%. That is a compound annual growth rate of 12.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 516.23M | -30.59% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.66B |
| Genus | 1.53B |
| Avacta Group | 313.83M |
| PureTech Health | 293.08M |
| Scancell Holdings | 116.37M |
| Bioventix | 90.39M |
| 4basebio | 73.81M |
| Faron Pharmaceuticals Oy | 72.43M |